nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—type 2 diabetes mellitus	0.266	1	CbGaD
Lenalidomide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0709	0.277	CbGbCtD
Lenalidomide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0632	0.247	CbGbCtD
Lenalidomide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0457	0.178	CbGbCtD
Lenalidomide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0314	0.123	CbGbCtD
Lenalidomide—ABCB1—Glyburide—type 2 diabetes mellitus	0.0234	0.0914	CbGbCtD
Lenalidomide—TNFSF11—leg—type 2 diabetes mellitus	0.0224	0.225	CbGeAlD
Lenalidomide—ABCB1—Losartan—type 2 diabetes mellitus	0.0214	0.0836	CbGbCtD
Lenalidomide—TNFSF11—hindlimb—type 2 diabetes mellitus	0.02	0.201	CbGeAlD
Lenalidomide—CDH5—artery—type 2 diabetes mellitus	0.00922	0.0925	CbGeAlD
Lenalidomide—CDH5—endothelium—type 2 diabetes mellitus	0.00779	0.0781	CbGeAlD
Lenalidomide—CDH5—cardiovascular system—type 2 diabetes mellitus	0.0032	0.0321	CbGeAlD
Lenalidomide—CDH5—cortex of kidney—type 2 diabetes mellitus	0.00305	0.0306	CbGeAlD
Lenalidomide—PTGS2—leg—type 2 diabetes mellitus	0.00291	0.0292	CbGeAlD
Lenalidomide—CDH5—adipose tissue—type 2 diabetes mellitus	0.00283	0.0283	CbGeAlD
Lenalidomide—CRBN—islet of Langerhans—type 2 diabetes mellitus	0.00282	0.0282	CbGeAlD
Lenalidomide—PTGS2—hindlimb—type 2 diabetes mellitus	0.0026	0.0261	CbGeAlD
Lenalidomide—CRBN—retina—type 2 diabetes mellitus	0.00241	0.0241	CbGeAlD
Lenalidomide—Thalidomide—NFKB1—type 2 diabetes mellitus	0.00236	0.313	CrCbGaD
Lenalidomide—CRBN—nephron tubule—type 2 diabetes mellitus	0.00227	0.0227	CbGeAlD
Lenalidomide—CDH5—liver—type 2 diabetes mellitus	0.00198	0.0199	CbGeAlD
Lenalidomide—CRBN—pancreas—type 2 diabetes mellitus	0.00198	0.0198	CbGeAlD
Lenalidomide—CRBN—cortex of kidney—type 2 diabetes mellitus	0.00194	0.0195	CbGeAlD
Lenalidomide—CRBN—adipose tissue—type 2 diabetes mellitus	0.0018	0.018	CbGeAlD
Lenalidomide—PTGS2—artery—type 2 diabetes mellitus	0.0016	0.016	CbGeAlD
Lenalidomide—PTGS2—endothelium—type 2 diabetes mellitus	0.00135	0.0135	CbGeAlD
Lenalidomide—CRBN—liver—type 2 diabetes mellitus	0.00126	0.0126	CbGeAlD
Lenalidomide—Pomalidomide—TNF—type 2 diabetes mellitus	0.00112	0.149	CrCbGaD
Lenalidomide—Pomalidomide—CYP1A2—type 2 diabetes mellitus	0.000821	0.109	CrCbGaD
Lenalidomide—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000767	0.00769	CbGeAlD
Lenalidomide—Thalidomide—TNF—type 2 diabetes mellitus	0.000722	0.096	CrCbGaD
Lenalidomide—Thalidomide—CYP2E1—type 2 diabetes mellitus	0.000556	0.0739	CrCbGaD
Lenalidomide—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000554	0.00556	CbGeAlD
Lenalidomide—Pomalidomide—CYP3A4—type 2 diabetes mellitus	0.000544	0.0722	CrCbGaD
Lenalidomide—PTGS2—kidney—type 2 diabetes mellitus	0.000542	0.00544	CbGeAlD
Lenalidomide—PTGS2—pancreas—type 2 diabetes mellitus	0.000539	0.0054	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—type 2 diabetes mellitus	0.000532	0.0707	CrCbGaD
Lenalidomide—Thalidomide—CYP1A2—type 2 diabetes mellitus	0.000529	0.0703	CrCbGaD
Lenalidomide—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000489	0.0049	CbGeAlD
Lenalidomide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000474	0.00475	CbGeAlD
Lenalidomide—ABCB1—retina—type 2 diabetes mellitus	0.000405	0.00406	CbGeAlD
Lenalidomide—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000382	0.00383	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—type 2 diabetes mellitus	0.000343	0.0456	CrCbGaD
Lenalidomide—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000343	0.00344	CbGeAlD
Lenalidomide—PTGS2—liver—type 2 diabetes mellitus	0.000343	0.00344	CbGeAlD
Lenalidomide—ABCB1—kidney—type 2 diabetes mellitus	0.000336	0.00336	CbGeAlD
Lenalidomide—ABCB1—pancreas—type 2 diabetes mellitus	0.000333	0.00334	CbGeAlD
Lenalidomide—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000327	0.00328	CbGeAlD
Lenalidomide—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000302	0.00303	CbGeAlD
Lenalidomide—ABCB1—liver—type 2 diabetes mellitus	0.000212	0.00213	CbGeAlD
Lenalidomide—Anxiety—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000272	CcSEcCtD
Lenalidomide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.65e-05	0.000272	CcSEcCtD
Lenalidomide—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.65e-05	0.000272	CcSEcCtD
Lenalidomide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.64e-05	0.000272	CcSEcCtD
Lenalidomide—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000272	CcSEcCtD
Lenalidomide—Vertigo—Losartan—type 2 diabetes mellitus	7.63e-05	0.000271	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000271	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000271	CcSEcCtD
Lenalidomide—Somnolence—Valsartan—type 2 diabetes mellitus	7.62e-05	0.000271	CcSEcCtD
Lenalidomide—Syncope—Losartan—type 2 diabetes mellitus	7.61e-05	0.000271	CcSEcCtD
Lenalidomide—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.6e-05	0.00027	CcSEcCtD
Lenalidomide—Leukopenia—Losartan—type 2 diabetes mellitus	7.6e-05	0.00027	CcSEcCtD
Lenalidomide—Discomfort—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.00027	CcSEcCtD
Lenalidomide—Skin disorder—Metformin—type 2 diabetes mellitus	7.58e-05	0.00027	CcSEcCtD
Lenalidomide—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000269	CcSEcCtD
Lenalidomide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.54e-05	0.000268	CcSEcCtD
Lenalidomide—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000268	CcSEcCtD
Lenalidomide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000268	CcSEcCtD
Lenalidomide—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.51e-05	0.000267	CcSEcCtD
Lenalidomide—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000267	CcSEcCtD
Lenalidomide—Palpitations—Losartan—type 2 diabetes mellitus	7.5e-05	0.000267	CcSEcCtD
Lenalidomide—Nausea—Glimepiride—type 2 diabetes mellitus	7.48e-05	0.000266	CcSEcCtD
Lenalidomide—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000266	CcSEcCtD
Lenalidomide—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.46e-05	0.000265	CcSEcCtD
Lenalidomide—Nausea—Sitagliptin—type 2 diabetes mellitus	7.46e-05	0.000265	CcSEcCtD
Lenalidomide—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000265	CcSEcCtD
Lenalidomide—Asthenia—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000265	CcSEcCtD
Lenalidomide—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.45e-05	0.000265	CcSEcCtD
Lenalidomide—Anorexia—Metformin—type 2 diabetes mellitus	7.44e-05	0.000264	CcSEcCtD
Lenalidomide—Cough—Losartan—type 2 diabetes mellitus	7.41e-05	0.000263	CcSEcCtD
Lenalidomide—Urticaria—Gliclazide—type 2 diabetes mellitus	7.41e-05	0.000263	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000263	CcSEcCtD
Lenalidomide—Alopecia—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000263	CcSEcCtD
Lenalidomide—Fatigue—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000263	CcSEcCtD
Lenalidomide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000262	CcSEcCtD
Lenalidomide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000262	CcSEcCtD
Lenalidomide—Oedema—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000262	CcSEcCtD
Lenalidomide—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.36e-05	0.000262	CcSEcCtD
Lenalidomide—Pruritus—Glyburide—type 2 diabetes mellitus	7.35e-05	0.000261	CcSEcCtD
Lenalidomide—Mental disorder—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000261	CcSEcCtD
Lenalidomide—Constipation—Valsartan—type 2 diabetes mellitus	7.33e-05	0.000261	CcSEcCtD
Lenalidomide—Infection—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.00026	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.31e-05	0.00026	CcSEcCtD
Lenalidomide—Fatigue—Orlistat—type 2 diabetes mellitus	7.3e-05	0.00026	CcSEcCtD
Lenalidomide—Hypotension—Metformin—type 2 diabetes mellitus	7.29e-05	0.000259	CcSEcCtD
Lenalidomide—Erythema—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000259	CcSEcCtD
Lenalidomide—Malnutrition—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000259	CcSEcCtD
Lenalidomide—Shock—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000258	CcSEcCtD
Lenalidomide—Pain—Orlistat—type 2 diabetes mellitus	7.24e-05	0.000257	CcSEcCtD
Lenalidomide—Arthralgia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000257	CcSEcCtD
Lenalidomide—Myalgia—Losartan—type 2 diabetes mellitus	7.23e-05	0.000257	CcSEcCtD
Lenalidomide—Chest pain—Losartan—type 2 diabetes mellitus	7.23e-05	0.000257	CcSEcCtD
Lenalidomide—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.22e-05	0.000257	CcSEcCtD
Lenalidomide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000257	CcSEcCtD
Lenalidomide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000256	CcSEcCtD
Lenalidomide—Anxiety—Losartan—type 2 diabetes mellitus	7.2e-05	0.000256	CcSEcCtD
Lenalidomide—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000256	CcSEcCtD
Lenalidomide—Rash—Bromocriptine—type 2 diabetes mellitus	7.16e-05	0.000255	CcSEcCtD
Lenalidomide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.16e-05	0.000254	CcSEcCtD
Lenalidomide—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000254	CcSEcCtD
Lenalidomide—Tension—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000254	CcSEcCtD
Lenalidomide—Discomfort—Losartan—type 2 diabetes mellitus	7.14e-05	0.000254	CcSEcCtD
Lenalidomide—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000254	CcSEcCtD
Lenalidomide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000253	CcSEcCtD
Lenalidomide—Headache—Bromocriptine—type 2 diabetes mellitus	7.12e-05	0.000253	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.11e-05	0.000253	CcSEcCtD
Lenalidomide—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.11e-05	0.000253	CcSEcCtD
Lenalidomide—Nervousness—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000251	CcSEcCtD
Lenalidomide—Dry mouth—Losartan—type 2 diabetes mellitus	7.07e-05	0.000251	CcSEcCtD
Lenalidomide—Anorexia—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.00025	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000249	CcSEcCtD
Lenalidomide—Paraesthesia—Metformin—type 2 diabetes mellitus	7.01e-05	0.000249	CcSEcCtD
Lenalidomide—Muscle spasms—Ramipril—type 2 diabetes mellitus	7e-05	0.000249	CcSEcCtD
Lenalidomide—Confusional state—Losartan—type 2 diabetes mellitus	6.99e-05	0.000248	CcSEcCtD
Lenalidomide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.98e-05	0.000248	CcSEcCtD
Lenalidomide—Dyspnoea—Metformin—type 2 diabetes mellitus	6.96e-05	0.000247	CcSEcCtD
Lenalidomide—Somnolence—Metformin—type 2 diabetes mellitus	6.94e-05	0.000247	CcSEcCtD
Lenalidomide—Oedema—Losartan—type 2 diabetes mellitus	6.93e-05	0.000246	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.92e-05	0.000246	CcSEcCtD
Lenalidomide—Infection—Losartan—type 2 diabetes mellitus	6.88e-05	0.000245	CcSEcCtD
Lenalidomide—Hypotension—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000245	CcSEcCtD
Lenalidomide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.000244	CcSEcCtD
Lenalidomide—Dyspepsia—Metformin—type 2 diabetes mellitus	6.87e-05	0.000244	CcSEcCtD
Lenalidomide—Tremor—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000243	CcSEcCtD
Lenalidomide—Shock—Losartan—type 2 diabetes mellitus	6.82e-05	0.000242	CcSEcCtD
Lenalidomide—Urticaria—Valsartan—type 2 diabetes mellitus	6.81e-05	0.000242	CcSEcCtD
Lenalidomide—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.8e-05	0.000242	CcSEcCtD
Lenalidomide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.79e-05	0.000241	CcSEcCtD
Lenalidomide—Decreased appetite—Metformin—type 2 diabetes mellitus	6.78e-05	0.000241	CcSEcCtD
Lenalidomide—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.77e-05	0.000241	CcSEcCtD
Lenalidomide—Tachycardia—Losartan—type 2 diabetes mellitus	6.76e-05	0.000241	CcSEcCtD
Lenalidomide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.76e-05	0.00024	CcSEcCtD
Lenalidomide—Nausea—Bromocriptine—type 2 diabetes mellitus	6.75e-05	0.00024	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.74e-05	0.00024	CcSEcCtD
Lenalidomide—Fatigue—Metformin—type 2 diabetes mellitus	6.73e-05	0.000239	CcSEcCtD
Lenalidomide—Urticaria—Orlistat—type 2 diabetes mellitus	6.73e-05	0.000239	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000239	CcSEcCtD
Lenalidomide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.7e-05	0.000238	CcSEcCtD
Lenalidomide—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.69e-05	0.000238	CcSEcCtD
Lenalidomide—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.69e-05	0.000238	CcSEcCtD
Lenalidomide—Asthenia—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000238	CcSEcCtD
Lenalidomide—Agitation—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000238	CcSEcCtD
Lenalidomide—Constipation—Metformin—type 2 diabetes mellitus	6.67e-05	0.000237	CcSEcCtD
Lenalidomide—Angioedema—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000237	CcSEcCtD
Lenalidomide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.000235	CcSEcCtD
Lenalidomide—Anorexia—Losartan—type 2 diabetes mellitus	6.61e-05	0.000235	CcSEcCtD
Lenalidomide—Vomiting—Glyburide—type 2 diabetes mellitus	6.6e-05	0.000235	CcSEcCtD
Lenalidomide—Pruritus—Gliclazide—type 2 diabetes mellitus	6.6e-05	0.000235	CcSEcCtD
Lenalidomide—Malaise—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000233	CcSEcCtD
Lenalidomide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.56e-05	0.000233	CcSEcCtD
Lenalidomide—Rash—Glyburide—type 2 diabetes mellitus	6.55e-05	0.000233	CcSEcCtD
Lenalidomide—Somnolence—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000233	CcSEcCtD
Lenalidomide—Dermatitis—Glyburide—type 2 diabetes mellitus	6.54e-05	0.000233	CcSEcCtD
Lenalidomide—Vertigo—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000233	CcSEcCtD
Lenalidomide—Syncope—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000232	CcSEcCtD
Lenalidomide—Leukopenia—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000232	CcSEcCtD
Lenalidomide—Headache—Glyburide—type 2 diabetes mellitus	6.51e-05	0.000231	CcSEcCtD
Lenalidomide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.00023	CcSEcCtD
Lenalidomide—Hypotension—Losartan—type 2 diabetes mellitus	6.48e-05	0.00023	CcSEcCtD
Lenalidomide—Palpitations—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000229	CcSEcCtD
Lenalidomide—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.43e-05	0.000229	CcSEcCtD
Lenalidomide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000228	CcSEcCtD
Lenalidomide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000228	CcSEcCtD
Lenalidomide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.38e-05	0.000227	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.38e-05	0.000227	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000226	CcSEcCtD
Lenalidomide—Cough—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000226	CcSEcCtD
Lenalidomide—Fatigue—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000226	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.31e-05	0.000225	CcSEcCtD
Lenalidomide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.31e-05	0.000224	CcSEcCtD
Lenalidomide—Pain—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000224	CcSEcCtD
Lenalidomide—Constipation—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000224	CcSEcCtD
Lenalidomide—Insomnia—Losartan—type 2 diabetes mellitus	6.27e-05	0.000223	CcSEcCtD
Lenalidomide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000222	CcSEcCtD
Lenalidomide—Paraesthesia—Losartan—type 2 diabetes mellitus	6.22e-05	0.000221	CcSEcCtD
Lenalidomide—Urticaria—Metformin—type 2 diabetes mellitus	6.2e-05	0.00022	CcSEcCtD
Lenalidomide—Chest pain—Ramipril—type 2 diabetes mellitus	6.2e-05	0.00022	CcSEcCtD
Lenalidomide—Arthralgia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.00022	CcSEcCtD
Lenalidomide—Myalgia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.00022	CcSEcCtD
Lenalidomide—Dyspnoea—Losartan—type 2 diabetes mellitus	6.18e-05	0.00022	CcSEcCtD
Lenalidomide—Anxiety—Ramipril—type 2 diabetes mellitus	6.18e-05	0.00022	CcSEcCtD
Lenalidomide—Nausea—Glyburide—type 2 diabetes mellitus	6.17e-05	0.000219	CcSEcCtD
Lenalidomide—Abdominal pain—Metformin—type 2 diabetes mellitus	6.17e-05	0.000219	CcSEcCtD
Lenalidomide—Dizziness—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.000219	CcSEcCtD
Lenalidomide—Somnolence—Losartan—type 2 diabetes mellitus	6.16e-05	0.000219	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000219	CcSEcCtD
Lenalidomide—Asthenia—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000219	CcSEcCtD
Lenalidomide—Discomfort—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000218	CcSEcCtD
Lenalidomide—Dyspepsia—Losartan—type 2 diabetes mellitus	6.1e-05	0.000217	CcSEcCtD
Lenalidomide—Asthenia—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000216	CcSEcCtD
Lenalidomide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.000216	CcSEcCtD
Lenalidomide—Pruritus—Valsartan—type 2 diabetes mellitus	6.06e-05	0.000216	CcSEcCtD
Lenalidomide—Dry mouth—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000216	CcSEcCtD
Lenalidomide—Decreased appetite—Losartan—type 2 diabetes mellitus	6.02e-05	0.000214	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000214	CcSEcCtD
Lenalidomide—Confusional state—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000213	CcSEcCtD
Lenalidomide—Pruritus—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000213	CcSEcCtD
Lenalidomide—Fatigue—Losartan—type 2 diabetes mellitus	5.97e-05	0.000212	CcSEcCtD
Lenalidomide—Oedema—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000211	CcSEcCtD
Lenalidomide—Vomiting—Gliclazide—type 2 diabetes mellitus	5.93e-05	0.000211	CcSEcCtD
Lenalidomide—Pain—Losartan—type 2 diabetes mellitus	5.93e-05	0.000211	CcSEcCtD
Lenalidomide—Constipation—Losartan—type 2 diabetes mellitus	5.93e-05	0.000211	CcSEcCtD
Lenalidomide—Rash—Gliclazide—type 2 diabetes mellitus	5.88e-05	0.000209	CcSEcCtD
Lenalidomide—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000209	CcSEcCtD
Lenalidomide—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.86e-05	0.000208	CcSEcCtD
Lenalidomide—Urticaria—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000208	CcSEcCtD
Lenalidomide—Shock—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000208	CcSEcCtD
Lenalidomide—Headache—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.000208	CcSEcCtD
Lenalidomide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000207	CcSEcCtD
Lenalidomide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000207	CcSEcCtD
Lenalidomide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000207	CcSEcCtD
Lenalidomide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000207	CcSEcCtD
Lenalidomide—Tachycardia—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000206	CcSEcCtD
Lenalidomide—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.79e-05	0.000206	CcSEcCtD
Lenalidomide—Skin disorder—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000205	CcSEcCtD
Lenalidomide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000204	CcSEcCtD
Lenalidomide—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.71e-05	0.000203	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.67e-05	0.000202	CcSEcCtD
Lenalidomide—Dizziness—Valsartan—type 2 diabetes mellitus	5.67e-05	0.000201	CcSEcCtD
Lenalidomide—Anorexia—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000201	CcSEcCtD
Lenalidomide—Dizziness—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000199	CcSEcCtD
Lenalidomide—Asthenia—Metformin—type 2 diabetes mellitus	5.6e-05	0.000199	CcSEcCtD
Lenalidomide—Hypotension—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000197	CcSEcCtD
Lenalidomide—Nausea—Gliclazide—type 2 diabetes mellitus	5.54e-05	0.000197	CcSEcCtD
Lenalidomide—Pruritus—Metformin—type 2 diabetes mellitus	5.52e-05	0.000196	CcSEcCtD
Lenalidomide—Urticaria—Losartan—type 2 diabetes mellitus	5.51e-05	0.000196	CcSEcCtD
Lenalidomide—Body temperature increased—Losartan—type 2 diabetes mellitus	5.48e-05	0.000195	CcSEcCtD
Lenalidomide—Abdominal pain—Losartan—type 2 diabetes mellitus	5.48e-05	0.000195	CcSEcCtD
Lenalidomide—Vomiting—Valsartan—type 2 diabetes mellitus	5.45e-05	0.000194	CcSEcCtD
Lenalidomide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000193	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000193	CcSEcCtD
Lenalidomide—Rash—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000192	CcSEcCtD
Lenalidomide—Dermatitis—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000192	CcSEcCtD
Lenalidomide—Vomiting—Orlistat—type 2 diabetes mellitus	5.38e-05	0.000191	CcSEcCtD
Lenalidomide—Insomnia—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000191	CcSEcCtD
Lenalidomide—Headache—Valsartan—type 2 diabetes mellitus	5.37e-05	0.000191	CcSEcCtD
Lenalidomide—Diarrhoea—Metformin—type 2 diabetes mellitus	5.34e-05	0.00019	CcSEcCtD
Lenalidomide—Rash—Orlistat—type 2 diabetes mellitus	5.34e-05	0.00019	CcSEcCtD
Lenalidomide—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.34e-05	0.00019	CcSEcCtD
Lenalidomide—Dermatitis—Orlistat—type 2 diabetes mellitus	5.33e-05	0.00019	CcSEcCtD
Lenalidomide—Headache—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000189	CcSEcCtD
Lenalidomide—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000188	CcSEcCtD
Lenalidomide—Asthenia—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000188	CcSEcCtD
Lenalidomide—Somnolence—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000188	CcSEcCtD
Lenalidomide—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000186	CcSEcCtD
Lenalidomide—Pruritus—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000185	CcSEcCtD
Lenalidomide—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000184	CcSEcCtD
Lenalidomide—Dizziness—Metformin—type 2 diabetes mellitus	5.16e-05	0.000183	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000182	CcSEcCtD
Lenalidomide—Fatigue—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000182	CcSEcCtD
Lenalidomide—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.11e-05	0.000182	CcSEcCtD
Lenalidomide—Nausea—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000181	CcSEcCtD
Lenalidomide—Constipation—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000181	CcSEcCtD
Lenalidomide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000179	CcSEcCtD
Lenalidomide—Nausea—Orlistat—type 2 diabetes mellitus	5.03e-05	0.000179	CcSEcCtD
Lenalidomide—Asthenia—Losartan—type 2 diabetes mellitus	4.97e-05	0.000177	CcSEcCtD
Lenalidomide—Vomiting—Metformin—type 2 diabetes mellitus	4.96e-05	0.000176	CcSEcCtD
Lenalidomide—Rash—Metformin—type 2 diabetes mellitus	4.92e-05	0.000175	CcSEcCtD
Lenalidomide—Dermatitis—Metformin—type 2 diabetes mellitus	4.92e-05	0.000175	CcSEcCtD
Lenalidomide—Pruritus—Losartan—type 2 diabetes mellitus	4.9e-05	0.000174	CcSEcCtD
Lenalidomide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000174	CcSEcCtD
Lenalidomide—Headache—Metformin—type 2 diabetes mellitus	4.89e-05	0.000174	CcSEcCtD
Lenalidomide—Dizziness—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000173	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000173	CcSEcCtD
Lenalidomide—Diarrhoea—Losartan—type 2 diabetes mellitus	4.74e-05	0.000169	CcSEcCtD
Lenalidomide—Urticaria—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000168	CcSEcCtD
Lenalidomide—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000167	CcSEcCtD
Lenalidomide—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000167	CcSEcCtD
Lenalidomide—Vomiting—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000166	CcSEcCtD
Lenalidomide—Rash—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000165	CcSEcCtD
Lenalidomide—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000165	CcSEcCtD
Lenalidomide—Nausea—Metformin—type 2 diabetes mellitus	4.63e-05	0.000165	CcSEcCtD
Lenalidomide—Headache—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000164	CcSEcCtD
Lenalidomide—Dizziness—Losartan—type 2 diabetes mellitus	4.58e-05	0.000163	CcSEcCtD
Lenalidomide—Vomiting—Losartan—type 2 diabetes mellitus	4.41e-05	0.000157	CcSEcCtD
Lenalidomide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000156	CcSEcCtD
Lenalidomide—Nausea—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000156	CcSEcCtD
Lenalidomide—Rash—Losartan—type 2 diabetes mellitus	4.37e-05	0.000155	CcSEcCtD
Lenalidomide—Dermatitis—Losartan—type 2 diabetes mellitus	4.37e-05	0.000155	CcSEcCtD
Lenalidomide—Headache—Losartan—type 2 diabetes mellitus	4.34e-05	0.000154	CcSEcCtD
Lenalidomide—Asthenia—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000152	CcSEcCtD
Lenalidomide—Pruritus—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000149	CcSEcCtD
Lenalidomide—Nausea—Losartan—type 2 diabetes mellitus	4.12e-05	0.000146	CcSEcCtD
Lenalidomide—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000145	CcSEcCtD
Lenalidomide—Dizziness—Ramipril—type 2 diabetes mellitus	3.93e-05	0.00014	CcSEcCtD
Lenalidomide—Vomiting—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000134	CcSEcCtD
Lenalidomide—Rash—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000133	CcSEcCtD
Lenalidomide—Dermatitis—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000133	CcSEcCtD
Lenalidomide—Headache—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000132	CcSEcCtD
Lenalidomide—Nausea—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000126	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—SRC—type 2 diabetes mellitus	3e-05	0.000335	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.99e-05	0.000333	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	2.98e-05	0.000332	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.94e-05	0.000327	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.94e-05	0.000327	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.93e-05	0.000326	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PCK1—type 2 diabetes mellitus	2.84e-05	0.000317	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	2.84e-05	0.000316	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	2.84e-05	0.000316	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	2.84e-05	0.000316	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.8e-05	0.000312	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.8e-05	0.000312	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.78e-05	0.00031	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.78e-05	0.00031	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TLE4—type 2 diabetes mellitus	2.76e-05	0.000308	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.75e-05	0.000307	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	2.72e-05	0.000303	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	2.72e-05	0.000303	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.71e-05	0.000302	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.69e-05	0.000299	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.69e-05	0.000299	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HK1—type 2 diabetes mellitus	2.66e-05	0.000296	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.66e-05	0.000296	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.63e-05	0.000293	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	2.62e-05	0.000292	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	2.62e-05	0.000292	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.61e-05	0.00029	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.59e-05	0.000288	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.59e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	2.58e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	2.57e-05	0.000287	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.57e-05	0.000287	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GCKR—type 2 diabetes mellitus	2.57e-05	0.000286	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.54e-05	0.000283	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	2.53e-05	0.000282	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.53e-05	0.000282	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	2.53e-05	0.000282	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.53e-05	0.000281	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.51e-05	0.00028	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.5e-05	0.000278	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	2.46e-05	0.000274	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.45e-05	0.000273	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.45e-05	0.000273	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.45e-05	0.000273	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.4e-05	0.000268	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	2.38e-05	0.000265	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.37e-05	0.000264	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.37e-05	0.000264	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.37e-05	0.000264	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.37e-05	0.000264	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.37e-05	0.000264	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	2.35e-05	0.000262	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.34e-05	0.000261	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.33e-05	0.00026	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.29e-05	0.000255	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RBP4—type 2 diabetes mellitus	2.29e-05	0.000255	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.29e-05	0.000255	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.28e-05	0.000254	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.28e-05	0.000254	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	2.23e-05	0.000248	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.23e-05	0.000248	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.2e-05	0.000245	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.18e-05	0.000242	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	2.17e-05	0.000241	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	2.17e-05	0.000241	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.15e-05	0.00024	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	2.15e-05	0.00024	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.15e-05	0.00024	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	2.15e-05	0.00024	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	2.14e-05	0.000238	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.12e-05	0.000236	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.11e-05	0.000235	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.1e-05	0.000234	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTR—type 2 diabetes mellitus	2.09e-05	0.000233	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.07e-05	0.000231	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	2.06e-05	0.00023	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	2.05e-05	0.000229	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GCK—type 2 diabetes mellitus	2.04e-05	0.000227	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IAPP—type 2 diabetes mellitus	2.03e-05	0.000226	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—type 2 diabetes mellitus	2.02e-05	0.000225	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	2.01e-05	0.000224	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	2.01e-05	0.000224	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	2.01e-05	0.000224	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.01e-05	0.000224	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2e-05	0.000223	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.99e-05	0.000222	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.98e-05	0.000221	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.96e-05	0.000219	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.94e-05	0.000216	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.93e-05	0.000215	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.93e-05	0.000215	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.92e-05	0.000214	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.87e-05	0.000208	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.87e-05	0.000208	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.86e-05	0.000207	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.86e-05	0.000207	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.85e-05	0.000206	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.83e-05	0.000204	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.83e-05	0.000204	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.83e-05	0.000203	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.8e-05	0.0002	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.79e-05	0.0002	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.79e-05	0.0002	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.79e-05	0.0002	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.79e-05	0.0002	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.77e-05	0.000198	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.75e-05	0.000195	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.75e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.73e-05	0.000193	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.73e-05	0.000192	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.72e-05	0.000192	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.71e-05	0.000191	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.71e-05	0.000191	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.71e-05	0.000191	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.71e-05	0.00019	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.71e-05	0.00019	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.71e-05	0.00019	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.7e-05	0.000189	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.69e-05	0.000188	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.67e-05	0.000186	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.66e-05	0.000184	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.65e-05	0.000184	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.65e-05	0.000184	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.65e-05	0.000184	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.63e-05	0.000182	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.62e-05	0.00018	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.62e-05	0.00018	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.61e-05	0.00018	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.59e-05	0.000177	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.58e-05	0.000176	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.55e-05	0.000172	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.54e-05	0.000172	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.54e-05	0.000171	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.53e-05	0.000171	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.53e-05	0.000171	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.53e-05	0.000171	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.53e-05	0.00017	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.53e-05	0.00017	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.53e-05	0.00017	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.53e-05	0.00017	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.51e-05	0.000168	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.49e-05	0.000166	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.47e-05	0.000164	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.46e-05	0.000163	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.46e-05	0.000163	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.4e-05	0.000156	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.39e-05	0.000155	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.39e-05	0.000155	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.39e-05	0.000155	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	1.38e-05	0.000154	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.36e-05	0.000151	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.35e-05	0.000151	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	1.34e-05	0.000149	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.33e-05	0.000148	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	1.33e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.31e-05	0.000146	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOB—type 2 diabetes mellitus	1.3e-05	0.000145	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.27e-05	0.000141	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LPL—type 2 diabetes mellitus	1.25e-05	0.000139	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.24e-05	0.000139	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.24e-05	0.000139	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	1.22e-05	0.000136	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.22e-05	0.000136	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.21e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.21e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.21e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.2e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.18e-05	0.000132	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.17e-05	0.00013	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	1.17e-05	0.00013	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.15e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CCR5—type 2 diabetes mellitus	1.15e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	1.15e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.15e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	1.14e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	1.13e-05	0.000125	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	1.12e-05	0.000125	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.09e-05	0.000122	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.09e-05	0.000121	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.09e-05	0.000121	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.09e-05	0.000121	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.07e-05	0.000119	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.07e-05	0.000119	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.07e-05	0.000119	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.06e-05	0.000118	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.06e-05	0.000118	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.05e-05	0.000117	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.04e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.04e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.04e-05	0.000115	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.03e-05	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.03e-05	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.02e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.94e-06	0.000111	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	9.91e-06	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.83e-06	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.83e-06	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.79e-06	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—type 2 diabetes mellitus	9.73e-06	0.000108	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.59e-06	0.000107	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	9.43e-06	0.000105	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.43e-06	0.000105	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	9.39e-06	0.000105	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IRS1—type 2 diabetes mellitus	9.32e-06	0.000104	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	9.22e-06	0.000103	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	8.93e-06	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—INS—type 2 diabetes mellitus	8.92e-06	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	8.78e-06	9.78e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	8.75e-06	9.74e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	8.65e-06	9.63e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT2—type 2 diabetes mellitus	8.62e-06	9.61e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	8.19e-06	9.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	8.12e-06	9.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.12e-06	9.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	8.09e-06	9.01e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.98e-06	8.89e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—type 2 diabetes mellitus	7.82e-06	8.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	7.82e-06	8.72e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	7.75e-06	8.63e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	7.62e-06	8.49e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	7.54e-06	8.39e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.47e-06	8.32e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	7.4e-06	8.24e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	7.24e-06	8.07e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	7.22e-06	8.04e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	7.03e-06	7.83e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.94e-06	7.73e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	6.85e-06	7.63e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6.66e-06	7.42e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.55e-06	7.3e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.55e-06	7.3e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	6.53e-06	7.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	6.33e-06	7.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	6.22e-06	6.93e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	6.2e-06	6.91e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.13e-06	6.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SRC—type 2 diabetes mellitus	5.79e-06	6.45e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.4e-06	6.02e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.3e-06	5.9e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	5.17e-06	5.76e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EGFR—type 2 diabetes mellitus	5.07e-06	5.65e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.86e-06	5.41e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.64e-06	5.17e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.64e-06	5.17e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.25e-06	4.73e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—type 2 diabetes mellitus	3.9e-06	4.34e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.6e-06	4.01e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.01e-06	3.36e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.14e-06	2.38e-05	CbGpPWpGaD
